Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Understanding genetic risk factors for common side effects of antidepressant medications

View ORCID ProfileAdrian I. Campos, Aoibhe Mulcahy, Jackson G. Thorp, View ORCID ProfileNaomi R. Wray, Enda M. Byrne, Penelope A. Lind, View ORCID ProfileSarah E. Medland, Nicholas G. Martin, View ORCID ProfileIan B. Hickie, View ORCID ProfileMiguel E. Rentería
doi: https://doi.org/10.1101/2021.07.12.21260397
Adrian I. Campos
1Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane QLD Australia
2Faculty of Medicine, The University of Queensland, Brisbane QLD Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Adrian I. Campos
  • For correspondence: adrian.campos@qimrberghofer.edu.au miguel.renteria@qimrberghofer.edu.au
Aoibhe Mulcahy
1Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane QLD Australia
3School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Brisbane, Queensland, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jackson G. Thorp
1Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane QLD Australia
2Faculty of Medicine, The University of Queensland, Brisbane QLD Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Naomi R. Wray
4Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD Australia
5Queensland Brain Institute, The University of Queensland, Brisbane QLD Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Naomi R. Wray
Enda M. Byrne
4Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD Australia
6Child Health Research Centre, The University of Queensland, Brisbane QLD Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Penelope A. Lind
1Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane QLD Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sarah E. Medland
1Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane QLD Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sarah E. Medland
Nicholas G. Martin
1Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane QLD Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ian B. Hickie
7Brain and Mind Centre, University of Sydney, Camperdown NSW Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ian B. Hickie
Miguel E. Rentería
1Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane QLD Australia
2Faculty of Medicine, The University of Queensland, Brisbane QLD Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Miguel E. Rentería
  • For correspondence: adrian.campos@qimrberghofer.edu.au miguel.renteria@qimrberghofer.edu.au
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Major depression is one of the most disabling health conditions internationally. In recent years, new generation antidepressant medicines have become very widely prescribed. While these medicines are efficacious, side effects are common and frequently result in discontinuation of treatment. Compared with specific pharmacological properties of the different medications, the relevance of individual vulnerability is understudied. We used data from the Australian Genetics of Depression Study to gain insights into the aetiology and genetic risk factors to antidepressant side effects. As expected, the most commonly reported longer-term side effects were reduced sexual function and weight gain. Importantly, participants reporting a specific side effect for one antidepressant were more likely to report the same side effect for other antidepressants, suggesting the presence of shared individual or pharmacological factors. Depression Polygenic Risk Scores (PRS) were associated with side effects that overlapped with depressive symptoms, including suicidality and anxiety. Body Mass Index PRS were strongly associated with weight gain from all medications. PRS for headaches were associated with headaches from sertraline. Insomnia PRS showed some evidence of predicting insomnia from amitriptyline and escitalopram. Our results suggest a set of common factors underlying the risk for antidepressant side effects. These factors seem to be, at least in part, explained by genetic liability related to depression severity and the nature of the side effect. Future studies on the genetic aetiology of side effects will enable insights into their underlying mechanisms and the possibility of risk stratification and prophylaxis strategies.

Competing Interest Statement

IBH has been commissioner of Australia National Mental Health Commission, Co-director of Health & Policy at the Brain & Mind Centre, University of Sydney. Led community-based and pharmaceutical industry-supported projects (Wyeth, Eli Lilly, Servier, Pfizer, AstraZeneca) focused on the identification and better management of anxiety and depression. Member of the Medical Advisory Panel for Medibank Private until October 2017. A board member of Psychosis Australia Trust. A member of the Veterans Mental Health Clinical Reference Group. Chief Scientific Advisor to and an equity shareholder in Innowell. AIC, AM, NGM, JGT, PAL, SEM, PL, JGT, NRW, EMB and MER have nothing to disclose.

Funding Statement

Data collection for AGDS was possible thanks to funding from the Australian National Health & Medical Research Council (NHMRC) to NGM, NRW, SEM, IHB, EMB, PAL (GNT1086683) and Medical Research Future Fund (APP1200644). MER thanks the support of NHMRC and the Australian Research Council (ARC) through an NHMRC-ARC Dementia Research Development Fellowship (GNT1102821). SEM is supported in part by NHMRC investigator grant APP1172917.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The QIMR Berghofer Medical Research Institute Human Research Ethics Committee approved all questionnaires and research procedures (project 2118).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Summary data on prevalence and effects described in this manuscript is available in the supplementary data. GWAS summary statistics used in this study are publicly available and have been disclosed but are also available upon request. Code related to this study data analysis is available upon request from the authors. Access to the AGDS data is restricted due to the ethical guidelines governing the study.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted July 16, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Understanding genetic risk factors for common side effects of antidepressant medications
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Understanding genetic risk factors for common side effects of antidepressant medications
Adrian I. Campos, Aoibhe Mulcahy, Jackson G. Thorp, Naomi R. Wray, Enda M. Byrne, Penelope A. Lind, Sarah E. Medland, Nicholas G. Martin, Ian B. Hickie, Miguel E. Rentería
medRxiv 2021.07.12.21260397; doi: https://doi.org/10.1101/2021.07.12.21260397
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Understanding genetic risk factors for common side effects of antidepressant medications
Adrian I. Campos, Aoibhe Mulcahy, Jackson G. Thorp, Naomi R. Wray, Enda M. Byrne, Penelope A. Lind, Sarah E. Medland, Nicholas G. Martin, Ian B. Hickie, Miguel E. Rentería
medRxiv 2021.07.12.21260397; doi: https://doi.org/10.1101/2021.07.12.21260397

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Psychiatry and Clinical Psychology
Subject Areas
All Articles
  • Addiction Medicine (215)
  • Allergy and Immunology (495)
  • Anesthesia (106)
  • Cardiovascular Medicine (1093)
  • Dentistry and Oral Medicine (195)
  • Dermatology (141)
  • Emergency Medicine (274)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (499)
  • Epidemiology (9758)
  • Forensic Medicine (5)
  • Gastroenterology (480)
  • Genetic and Genomic Medicine (2304)
  • Geriatric Medicine (222)
  • Health Economics (462)
  • Health Informatics (1554)
  • Health Policy (732)
  • Health Systems and Quality Improvement (602)
  • Hematology (236)
  • HIV/AIDS (501)
  • Infectious Diseases (except HIV/AIDS) (11634)
  • Intensive Care and Critical Care Medicine (616)
  • Medical Education (236)
  • Medical Ethics (67)
  • Nephrology (257)
  • Neurology (2140)
  • Nursing (134)
  • Nutrition (335)
  • Obstetrics and Gynecology (426)
  • Occupational and Environmental Health (517)
  • Oncology (1172)
  • Ophthalmology (363)
  • Orthopedics (128)
  • Otolaryngology (220)
  • Pain Medicine (145)
  • Palliative Medicine (50)
  • Pathology (309)
  • Pediatrics (694)
  • Pharmacology and Therapeutics (298)
  • Primary Care Research (265)
  • Psychiatry and Clinical Psychology (2173)
  • Public and Global Health (4648)
  • Radiology and Imaging (775)
  • Rehabilitation Medicine and Physical Therapy (455)
  • Respiratory Medicine (623)
  • Rheumatology (274)
  • Sexual and Reproductive Health (225)
  • Sports Medicine (210)
  • Surgery (250)
  • Toxicology (43)
  • Transplantation (120)
  • Urology (94)